Ken Griffin
STLN

Ken Griffin’s Starling Oncology, Inc. Common Stock STLN Stock Holding History

Ken Griffin’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$133K Buy
43,400
+16,600
+62% +$50.9K ﹤0.01% 11785
2025
Q4 		$95.4K Buy
26,800
+12,400
+86% +$46K ﹤0.01% 11682
2025
Q3 		$50.3K Buy
+14,400
New +$49.3K ﹤0.01% 12205

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ken Griffin's STLN Position: Q1 2026 in Review

Ken Griffin opened a new position in Starling Oncology, Inc. Common Stock (STLN) in Q1 2026: 608,267 shares worth $1.87M. The stake represents ﹤0.01% of the portfolio and ranks #6215 among its holdings. This is a return to the name: Ken Griffin previously reported a position in STLN as recently as Q3 2025.

Ken Griffin first reported a position in STLN in Q1 2021 and has held it in 11 quarters since. The position peaked at $14.6M in Q3 2021. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Ken Griffin held 608,267 shares of Starling Oncology, Inc. Common Stock worth $1.87M as of Q1 2026.
  • Starling Oncology, Inc. Common Stock was a new Ken Griffin position in Q1 2026.
  • Starling Oncology, Inc. Common Stock made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #6215 holding.
  • Ken Griffin first reported a position in Starling Oncology, Inc. Common Stock in Q1 2021 and has held it in 11 quarters since.
  • Ken Griffin's Starling Oncology, Inc. Common Stock position peaked at $14.6M in Q3 2021.
  • 115 funds tracked by Wall St. Rank held Starling Oncology, Inc. Common Stock as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.